Saniona AB Stock Nasdaq Stockholm
Equities
SE0005794617
Biotechnology & Medical Research
Sales 2023 | 16.84M 1.55M | Sales 2024 * | 62M 5.72M | Capitalization | 198M 18.24M |
---|---|---|---|---|---|
Net income 2023 | -95M -8.76M | Net income 2024 * | -37M -3.41M | EV / Sales 2023 | 15.3 x |
Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3.19 x |
P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 69.76% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 10-12-31 | |
Thomas Feldthus
CEO | Chief Executive Officer | 64 | 10-12-31 |
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jørgen Drejer
FOU | Founder | 69 | 10-12-31 |
Director/Board Member | 66 | 14-12-31 | |
Anna Ljung
BRD | Director/Board Member | 44 | 18-01-18 |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.08% | 22.2B | |
-16.53% | 21.23B | |
-8.54% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |